| Date | Time | Source | Headline | Symbol | Company |
| 05/13/2024 | 1:40AM | Business Wire | Hai Robotics Deploys Goods-to-Person Solution in L'Oréal China's First SMART Fulfillment Center | | |
| 05/13/2024 | 1:30AM | GlobeNewswire Inc. | BGHL (GBP): NAV(s) | EU:BGHS | Boussard and Gavaudan Holding |
| 05/13/2024 | 1:30AM | Business Wire | Oregon Therapeutics et Lantern Pharma lancent une collaboration stratégique dans le domaine de l’intelligence artificielle pour optimiser le développement du XCE853, premier candidat médicament de sa catégorie, un puissant inhibiteur... | NASDAQ:LTRN | Lantern Pharma Inc |
| 05/13/2024 | 1:30AM | GlobeNewswire Inc. | BGHL (EUR): NAV(s) | EU:BGHL | Boussard And Gavaudan Holding Limited |
| 05/13/2024 | 1:30AM | GlobeNewswire Inc. | BGHL (GBP): NAV(s) | LSE:BGHS | Boussard & Gavaudan Holding Limited |
| 05/13/2024 | 1:30AM | GlobeNewswire Inc. | BGHL (EUR): NAV(s) | LSE:BGHL | Boussard & Gavaudan Holding Limited |
| 05/13/2024 | 1:30AM | PR Newswire (US) | XRP Healthcare Solidifies Presence in Uganda with Trademark Registration Success | | |
| 05/13/2024 | 1:30AM | PR Newswire (US) | XRP Healthcare Solidifies Presence in Uganda with Trademark Registration Success | | |
| 05/13/2024 | 1:29AM | PR Newswire (Canada) | BGI-HL OHA Lab inaugurated in Harbin, initiating colorectal cancer risk assessment for 800,000 | | |
| 05/13/2024 | 1:29AM | PR Newswire (US) | BGI-HL OHA Lab inaugurated in Harbin, initiating colorectal cancer risk assessment for 800,000 | | |
| 05/13/2024 | 1:16AM | Business Wire | Almirall Delivers Strong Start of 2024 – Q1 Net Sales Growth of 6.6% Overall and 18% in the European Dermatology Business, Driven by Biologics and Solid Performance of Broad Product Portfolio | | |
| 05/13/2024 | 1:15AM | Business Wire | The Eurofins Network Expands Battery Testing Services, Supporting Client Acceleration of Battery Innovation | NYSE:ERF | Enerplus Corporation |
| 05/13/2024 | 1:05AM | Alliance News |  QatarEnergy acquires stake in two Exxon-operated Egypt offshore blocks | LSE:0R1M | Exxon Mobil Corp |
| 05/13/2024 | 1:03AM | Alliance News | Microsoft, Amazon to invest billions in French tech | LSE:0R1O | Amazon.com Inc |
| 05/13/2024 | 1:03AM | Alliance News | Microsoft, Amazon to invest billions in French tech | LSE:0QYP | Microsoft Corp |
| 05/13/2024 | 1:01AM | GlobeNewswire Inc. | Norsk Hydro: New Hydro CEO accelerating growth, value creation and sustainability to change the game for aluminium | TG:NHY | Lucapa Diamond Company Ltd |
| 05/13/2024 | 1:01AM | GlobeNewswire Inc. | Norsk Hydro: New Hydro CEO accelerating growth, value creation and sustainability to change the game for aluminium | TG:A2R0MA | Norsk Hydro ASA |
| 05/13/2024 | 1:00AM | GlobeNewswire Inc. | Corbion reports the progress of its € 20 million share buyback program 6 May – 10 May 2024 | EU:CRBN | Corbion N.V. |
| 05/13/2024 | 1:00AM | GlobeNewswire Inc. | Communiqué de presse : Sanofi investit plus d’un milliard d’euros supplémentaires dans la production de médicaments en France, en plus des 2,5 milliards d’euros déjà engagés dans de grands projets de souveraineté sanitaire | BIT:1SAN | Sanofi |
| 05/13/2024 | 1:00AM | GlobeNewswire Inc. | Air France-KLM a remboursé les 48 millions d'euros restants d'OCEANE à échéance 2026 | TG:AFR | Air France KLM |
| 05/13/2024 | 1:00AM | GlobeNewswire Inc. | Air France-KLM a remboursé les 48 millions d'euros restants d'OCEANE à échéance 2026 | LSE:AIRF | Air France-Klm |
| 05/13/2024 | 1:00AM | GlobeNewswire Inc. | Press Release: Sanofi adds over €1 billion for biomanufacturing to €2.5 billion already committed in major projects in France to support health sovereignty | BIT:SANF | Sanofi |
| 05/13/2024 | 1:00AM | GlobeNewswire Inc. | Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP) | NASDAQ:SNY | Sanofi |
| 05/13/2024 | 1:00AM | GlobeNewswire Inc. | Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP) | NASDAQ:REGN | Regeneron Pharmaceuticals Inc |
| 05/13/2024 | 1:00AM | GlobeNewswire Inc. | Valneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya Vaccine | TG:AYJ | Valneva SE |
| 05/13/2024 | 1:00AM | GlobeNewswire Inc. | Norsk Hydro: Changes in Hydro’s Executive Leadership Team | TG:A2R0MA | Norsk Hydro ASA |
| 05/13/2024 | 1:00AM | GlobeNewswire Inc. | Valneva annonce de nouveaux résultats positifs chez les adolescents pour l’étude pivot de Phase 3 de son vaccin à dose unique contre le chikungunya | TG:AYJ | Valneva SE |
| 05/13/2024 | 1:00AM | GlobeNewswire Inc. | Communiqué de presse : Sanofi investit plus d’un milliard d’euros supplémentaires dans la production de médicaments en France, en plus des 2,5 milliards d’euros déjà engagés dans de grands projets de souveraineté sanitaire | TG:SNW | Sanofi |
| 05/13/2024 | 1:00AM | GlobeNewswire Inc. | Valneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya Vaccine | EU:VLA | Valneva SE |
| 05/13/2024 | 1:00AM | GlobeNewswire Inc. | Valneva annonce de nouveaux résultats positifs chez les adolescents pour l’étude pivot de Phase 3 de son vaccin à dose unique contre le chikungunya | EU:VLA | Valneva SE |